Your session is about to expire
← Back to Search
Dysport for Tourette Syndrome
Study Summary
This trial is testing the efficacy of Abobotulinum toxin A, injected into the affected vocal cords, for treating primary Tourette's syndrome. The study will involve an injection of 2.5 units of Dysport on each side of the affected vocal cords for patients with a diagnosis of Primary Tourette's syndrome. The patients will also complete a self assessment survey on how vocal tics affect their daily lives.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am willing and able to agree to participate in the study, or if under 21, my guardian has consented and I agree.You have been diagnosed with a substance dependence disorder.I am not pregnant or breastfeeding.I am allergic to Dysport or similar medications.Previous Botox treatments didn't work for me or caused severe side effects.I plan to receive Botox for reasons other than Tourette Syndrome.I have a sexually transmitted disease like HIV, Herpes, or Gonorrhea.I have an autoimmune disease such as Myasthenia Gravis.I have some form of cognitive impairment.I am of childbearing age and my pregnancy test is negative.I am between 18 and 65 years old and have been diagnosed with Tourette Syndrome or chronic Tic Disorder for over a year.I can and will give my consent, or if under 21, my guardian will.I am between 18 and 65 years old and have been diagnosed with Tourette Syndrome or chronic Tic Disorder for over a year.You have severe tic symptoms, with a score of 20 or higher on the Yale Global Tic Severity Scale if diagnosed with Tourette syndrome, or a score of 14 or higher for chronic tic disorder.I am of childbearing age and my pregnancy test is negative.People with intellectual disabilities.My tetanus shots are current.My condition is a type of Obsessive Compulsive Disorder.I have a progressive brain disorder or one caused by birth, injury, or past infection.I am taking multiple medications for tics or ADHD, and my doses have been stable for less than 6 weeks.I cannot receive treatments with any botulinum toxin products.My tetanus shots are current.I am currently taking medications that affect my nervous system.Your tic symptoms are severe, with a score of 20 or more on the Yale Global Tic Severity Scale if you have Tourette Syndrome, or a score of 14 or more for Chronic Tic disorder.I have a major psychiatric disorder like schizophrenia or bipolar that is not stable.
- Group 1: Abobotulinum toxin A
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To what end is Abobotulinum toxin A typically administered?
"Abobotulinum toxin A is a proven remedy for urinary incontinence, spinal cord issues, and even botox treatments."
Is the patient eligibility cut-off for this experiment 85 years of age or lower?
"The parameters for enrolment in this trial involve patients who are between 18 and 65 years of age. For those younger than 18, there are 390 studies available, while 1048 can be found if the patient is over 65."
Has Abobotulinum toxin A been tested in other scientific investigations?
"Currently, there are 61 Abobotulinum toxin A studies in progress with 20 of those trials being Phase 3. The majority are located in Farmington Hills, Michigan; however, this medication is also tested at 759 different sites around the world."
What is the upper limit for participants in this research endeavor?
"Unfortunately, this clinical trial is closed to new participants. Its initial posting date was January 1st 2014 with its final update on February 9th 2015. Nonetheless, if you are looking for other studies related tourette syndrome 1409 studies and 61 trials featuring Abobotulinum toxin A presently exist that are actively recruiting patients."
Is enrollment still available for this clinical experiment?
"The trial's page on clinicaltrials.gov indicates that recruitment has ceased, as this medical study was first posted in January 2014 and last updated nearly a year later. Yet, there are 1,470 other studies still actively recruiting patients right now."
Are there any conditions to qualify for participation in this research project?
"This clinical trial is seeking 30 individuals with a diagnosis of Tourette syndrome (TS) or Chronic Tic Disorder, who are between the ages 18 and 65. All participants should be up-to-date on their tetanus immunization, receive informed consent from either themselves if older than 21 years old or their legal guardian/parent otherwise; they must have a Yale Global Tic Severity Scale score ≥20 for TS or ≥14 for chronic tics disorder, as well as provide evidence of not being pregnant via negative urine pregnancy test."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger